Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chaoju Eye Care HoldingsHKSE:02219 +6.57%93 Net Margin % is 10.54% as of Dec. 2025, which is 29% below its 10-year median of 14.76. GuruFocus rates HKSE:02219 with a GF Score™ of 93/100 and a GF Value™ of HK$3.47 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 671 Healthcare Providers & Services companies, Chaoju Eye Care Holdings ranks better than 85.54% on this metric.
The historical rank and industry rank for Chaoju Eye Care Holdings's Net Margin % or its related term are showing as below:
HKSE:02219'
s Net Margin % Range Over the Past 10 Years
Min: 6.12 Med: 14.76 Max: 18.96
Current: 13.47
HKSE:02219's Net Margin % is ranked better than 85.54% of 671
companies
in the Healthcare Providers & Services industry
Industry Median: 2.91
vs HKSE:02219: 13.47
Chaoju Eye Care Holdings (HKSE:02219) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Chaoju Eye Care Holdings Net Margin % Related Terms
Chaoju Eye Care Holdings Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:02219 vs HCA, THC, EHC: Net Margin % Comparison
For the Medical Care Facilities subindustry, Chaoju Eye Care Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chaoju Eye Care Holdings Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Chaoju Eye Care Holdings's Net Margin % distribution charts can be found below:
* The bar in red indicates where Chaoju Eye Care Holdings's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chaoju Eye Care Holdings (HKSE:02219) has a Net Margin % of 10.54% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Chaoju Eye Care Holdings and its competitors. This is 29% below median its historical median of 14.76. Over the past decade, Chaoju Eye Care Holdings' Net Margin % has ranged from 6.12 to 18.96. According to the industry distribution chart, Chaoju Eye Care Holdings ranks #97 out of 671 companies in the Healthcare Providers & Services industry, placing it in the top 14.5%.
Is Chaoju Eye Care Holdings' Net Margin % too high?
Chaoju Eye Care Holdings' current Net Margin % of 10.54% is 29% below median its 10-year median of 14.76. Over the past 10 years, this metric has ranged from a low of 6.12 to a high of 18.96. The Healthcare Providers & Services industry median Net Margin % is 2.91. Chaoju Eye Care Holdings' value of 10.54% is 262.2% above this industry median. Based on the distribution chart, Chaoju Eye Care Holdings ranks #97 out of 671 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Chaoju Eye Care Holdings has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chaoju Eye Care Holdings' Net Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Chaoju Eye Care Holdings ranks #97 out of 671 companies for Net Margin %. This places Chaoju Eye Care Holdings in the top 15% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.91. Chaoju Eye Care Holdings' value of 10.54% is 262.2% above this benchmark. Historically, Chaoju Eye Care Holdings' own Net Margin % has ranged from 6.12 to 18.96 over the past decade. While the company's 10-year median is 14.76 vs. the industry median of 2.91, Chaoju Eye Care Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.91, based on 671 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chaoju Eye Care Holdings's current Net Margin % of 10.54% is 262.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Chaoju Eye Care Holdings and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chaoju Eye Care Holdings's current Net Margin % is 10.54%, which is 29% below median its own 10-year median of 14.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chaoju Eye Care Holdings stock overvalued right now?
Based on GuruFocus' analysis, Chaoju Eye Care Holdings (HKSE:02219) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$3.47, compared to a current price of HK$2.52 — trading 27.5% below its estimated fair value. The current Net Margin % is 10.54%, which is 29% below median its 10-year median of 14.76 and 262.2% above the Healthcare Providers & Services industry median of 2.91. Chaoju Eye Care Holdings' overall GF Score™ is 93/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Chaoju Eye Care Holdings (HKSE:02219), the current Net Margin % is 10.54% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chaoju Eye Care Holdings (HKSE:02219) Overvalued in 2026?
Based on GuruFocus' analysis, Chaoju Eye Care Holdings stock appears to be undervalued.
The current stock price of HK$2.52 is trading 27.5% below its estimated GF Value™ of HK$3.47.
GuruFocus considers Chaoju Eye Care Holdings to be Modestly Undervalued.
Key valuation signals for HKSE:02219:
Net Margin %: 10.54% (29% below median its 10-year median of 14.76)
GF Value™: HK$3.47 vs. price of HK$2.52 (27.5% below fair value)
Industry Position: 262.2% above the Healthcare Providers & Services median (#97 of 671)
No single metric tells the full story. See the HKSE:02219 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chaoju Eye Care Holdings Ltd is an ophthalmic medical service group in North China engaged in the provision of in-patient services, out-patient services, and sales of optical products. The company generates revenue from consumer ophthalmic services and basic ophthalmic services. The consumer ophthalmic services include treatments and prevention of various types of ophthalmic disorders, including refractive correction, myopia control, and the provision of optical products and services. The basic ophthalmic services include treatments of a wide range of common eye diseases, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases, and pediatric eye diseases.
93GF Score
Get the complete analysis for HKSE:02219
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02219 has been successfully added to your 
